Cite
MLA Citation
Sarah B Goldberg et al.. “Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.” Lancet oncology, vol. 17, no. 7, n.d., pp. 976–983. http://access.bl.uk/ark:/81055/vdc_100033761042.0x000010